Choose your location:

Choose a Language

Contact us

Archive

Strategy, appointments, major clinical, medical and regulatory advances, and partnerships: you can find all the latest Ipsen Group press releases here.

October 27, 2022
TAZVERIK® + R2 2L FL
Pipeline data
October 27, 2022
ONIVYDE® + 5-FU/LV + OXALIPLATIN 1L PDAC
Pipeline data
October 27, 2022
TAZVERIK ®(+ hormonotherapy) mCRPC
Pipeline data
October 27, 2022
TAZVERIK® (various combinations) R/R hematologic malignancies
Pipeline data
October 27, 2022
IPN60210 R/R multiple myeloma and R/R DLBCL
Pipeline data
October 27, 2022
CABOMETYX® + ATEZOLIZUMAB Solid tumors
Pipeline data
July 26, 2021
CABOMETYX® + ATEZOLIZUMAB Solid tumors
Pipeline data
July 26, 2021
CABOMETYX® + ATEZOLIZUMAB 1L HCC
Pipeline data
July 26, 2021
CABOMETYX + ATEZOLIZUMAB 2L NSCLC
Pipeline data
July 26, 2021
CABOMETYX® + ATEZOLIZUMAB 2L mCRPC
Pipeline data
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023